Incyte said on Monday its experimental drug has met the main goal in two separate late-stage studies testing it in patients with an inflammatory skin condition called hidradenitis suppurativa.

Joya Griffin, DVM, DACVD, discusses the concept of ‘food as medicine’ and how prescription diets can help restore the skin’s ...

The Department of Health recently reported that 7,598 cases of hand, foot and mouth disease (HFMD) were diagnosed between Jan. 1 and Feb. 22, 2025. This is about three times the number of cases from ...

GPs are failing to spot the symptoms of a drug-resistant 'super-fungus' thought to be spreading throughout the UK, experts ...

"We still don't know exactly what makes labor start. We know all about the mechanics and physiology, but we don't know what ...

After receiving a life-changing kidney transplant from my mother in 2012, I’ve come to appreciate just how vital these ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...

Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.

Lawrence F. Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the effectiveness of ruxolitinib cream as a nonsteroidal topical treatment for atopic ...